Aphidicolin

Aphidicolin

SCHEMBL20770430

CN(N=O)C(N)=O.C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]1C[C@@H]3C[C@@]12CC[C@]3(O)CO

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ POLA1 P09884 5/20 0.74
▸ LMNA P02545 1/20 0.74
▸ HTT P42858 1/20 0.74
▸ RECQL P46063 1/20 0.74
▸ SMN1; SMN2 Q16637 1/20 0.74
▸ HIF1A Q16665 1/20 0.74
▸ CYP2C19 P33261 1/20 0.63
▸ CYP3A4 P08684 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aphidicolin SCHEMBL20771749 0.91 LMNA (0.61) POLA1LMNAHTTRECQLSMN1; SMN2
Aphidicolin SCHEMBL8763668 0.86 POLA1 (1.00) POLA1LMNAHTTRECQLSMN1; SMN2
Aphidicolin SCHEMBL16610406 0.86 POLA1 (1.00) POLA1LMNAHTTRECQLSMN1; SMN2
Aphidicolin SCHEMBL14667945 0.86 POLA1 (1.00) POLA1LMNAHTTRECQLSMN1; SMN2
Aphidicolin SCHEMBL183956 0.86 POLA1 (1.00) POLA1LMNAHTTRECQLSMN1; SMN2
Aphidicolin SCHEMBL2332951 0.78 POLA1 (0.59) POLA1LMNAHTTRECQLSMN1; SMN2
Hydrochloric Acid SCHEMBL29351943 0.77 CYP2C19 (0.98) POLA1LMNAHTTRECQLSMN1; SMN2
Aphidicolin SCHEMBL20771139 0.76 POLA1 (0.71) POLA1LMNAHTTRECQLSMN1; SMN2
SCHEMBL14552897 0.73 LMNA (0.73) POLA1LMNAHTTRECQLSMN1; SMN2
SCHEMBL15747 0.71 CYP2C19 (0.70) POLA1LMNAHTTRECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019046303-A1 A METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-03-07 — — WO disclosed
Send feedback